Rimonabant Hydrochloride is a potent anti-obesity agent and an inverse agonist of the cannabinoid receptor CB1, historically developed to manage severe obesity and associated metabolic conditions such… Read more
Rimonabant Hydrochloride is a potent anti-obesity agent and an inverse agonist of the cannabinoid receptor CB1, historically developed to manage severe obesity and associated metabolic conditions such as type 2 diabetes by suppressing appetite through the blockade of endocannabinoid signaling. Pharmaceutical laboratories and analytical facilities utilize high-quality reference standards of this active pharmaceutical ingredient to support rigorous quality control, regulatory compliance, and method validation processes. This category includes the parent compound as well as critical related substances, such as the impurity 4-chloropropiophenone. Researchers and analytical chemists rely on these reference materials for impurity profiling, stability testing, and the development of accurate analytical methods to ensure the safety and efficacy of the drug substance. By providing essential impurity standards and related compounds, this collection facilitates precise identification and quantification throughout the pharmaceutical development and manufacturing lifecycle.